Beyond Borders: Strengthening Regional Cooperation to Combat
Lassa Fever and Emerging Infectious Diseases
Convite à apresentação de resumos
The West African Health Organisation invites researchers,
practitioners, and stakeholders to submit abstracts for
presentation at the
Lassa Fever International Conference 2025.
Submissions are welcome across all conference tracks and should
focus on Lassa Fever and emerging infectious diseases.
Note: Abstracts on Lassa Fever and other viral
hemorrhagic fevers will be prioritized.
Diretrizes para a apresentação de propostas:
-
Abstracts must be submitted via the official conference
submission platform. If you encounter any difficulties,
please contact abstracts@lfic2025.org
-
A data-limite para a apresentação de candidaturas é 24 de maio de 2025 às 23:59 GMT.
-
As apresentações aceites serão em formato
oral ou poster
ou poster.
-
Os resumos devem ser estruturados da seguinte forma:
- Introduction/Background – Provide context
and significance of the study.
- Methods – Describe study design, data
sources, and analysis approach.
- Results – Present key findings with relevant
data.
- Conclusion – Summarize key takeaways and
recommendations.
Âmbito da apresentação de propostas
We welcome submissions of original research, implementation
science studies and case studies and programmatic
experiences.
Opções de idioma
Abstracts may be submitted in any of the three official
ECOWAS languages which are English, French, Portuguese.
Ensure that your abstract is clear, concise, and emphasizes
the public health significance of your work. For further
details and to submit your abstract,
CLICK HERE
Tópicos
Abstracts will be accepted for the following conference pillars
and themes:
Pilar 1: Coordenação regional e preparação transfronteiriça
transfronteiriça
Temas
-
Regional Partnerships for Disease Control:
Fostering coordinated efforts among governments, health
organisations, research institutions, and partners to
improve outbreak preparedness and response.
- Enhancing Cross-Border Surveillance and
Data-sharing:
Promoting joint surveillance, data sharing and harmonized
response strategies among Member States to improve disease
monitoring.
- Integrating One Health approach in Disease
Prevention and Control:
Strengthening the collaboration of human, animal, and
environmental health sectors to improve disease detection
and response through a multi-sectoral approach.
Pilar 2: Avançar na investigação e nas contramedidas médicas para a
Febre de Lassa e outras febres hemorrágicas virais
Temas
- Innovations in Vaccine Development and Access:
Examining advancements in vaccine research, regulatory
challenges, and equitable access strategies.
- Strengthening Laboratory Networks for Timely
Diagnostics:
Expanding laboratory capacity, improving rapid diagnostic
tools, and enhancing sample/specimen transport systems
to ensure prompt and accurate detection.
- Advancements in Therapeutics: Exploring
novel treatment approaches, drug repurposing and combination
therapies for improved clinical outcomes.
- Sustainable Research Collaboration and Funding:
Promoting local research initiatives, fostering partnerships,
and establishing long-term funding mechanisms to advance
long-term disease control and prevention efforts.
Estrutura abstrata
Título (máximo 25 palavras)
The title should be informative yet concise, avoiding
subtitles where possible. Use sentence case, capitalizing only
proper nouns and scientific names (e.g., Plasmodium
falciparum). Do not use abbreviations or acronyms in the
title.
Pilar e subtema
Introdução/antecedentes
Provide the scientific context, rationale and public health significance
of the study. Given the diverse background of reviewers and attendees,
avoid assumptions about prior knowledge of the topic. Clearly articulate
the importance of the study and the key questions it aims to answer.
Include:
-
A brief description of the topic and its relevance to
public health
-
Questões de investigação ou hipóteses de estudo (se aplicável)
- Objectivos do estudo
Métodos
Outline the methodology used in the study, ensuring clarity and
replicability. Essential details include:
- Conceção do estudo
- Contexto do estudo
- População do estudo
- Critérios de elegibilidade e definições de casos (caso existam)
- Dimensão da amostra e métodos de amostragem
- Processos de gestão e análise de dados
Resultados
Present the key findings (both positive and negative) of the study
in alignment with the stated objectives. Ensure that:
-
Absolute numbers, percentages, rates and ratios are
provided where applicable.
-
A secção não inclui uma discussão dos resultados.
-
Data is included, as abstracts are standalone citable
documents.
Statements such as “Data will be discussed” should be avoided.
If analyses are ongoing, indicate that results are preliminary.
Conclusão:
Be concise and avoid repeating data from the results. This section
may include:
-
Interpretation of key findings and their implications for
public health.
-
Recommended public health actions that have been or should
implemented because of the study.
Note: Changes cannot be made to the final abstract after
submission. However, if significant changes occur after the
abstract submission, they should be highlighted during the
presentation.
Contagem de palavras e formatação:
-
Abstracts should not exceed 300 words (excluding title,
keywords, authors and affiliations).
- Texto alinhado à esquerda.
-
Tipo de letra: Times New Roman, espaçamento 1,5.
-
Subtítulos em negrito, seguidos de dois pontos.
- Não há tabelas, figuras ou imagens.
-
Use only standard or widely recognized abbreviations,
ensuring the full term is written at first mention.
- Itálico para os nomes científicos.
Autores
- First Author: Provide the first name, initials
of the middle name (if applicable), and the last name (e.g.,
David W. Meyers).
- Co-Authors: List each co-author in order of
contribution by typing their first and middle names as initials
followed by their last name in full (e.g., W. Grisham, M. S.
Pollock)
- Affiliations: Include the organisational affiliations
of the first author and all co-authors
- Corresponding Author: Indicate with an asterisk*
and provide their
email address and telephone number, plus their alternate contacts.
Palavras-chave
Please include 4 – 6 keywords that reflect the core topics of the
study. Use terms listed in the Medical Subject Headings (MeSH)
www.ncbi.nlm.nih.gov/mesh 
